药明康德：截至2025年4月8日前十大流通股东持股占比42.25%

Core Points - WuXi AppTec announced a plan to repurchase A-shares through centralized bidding on April 8, 2025 [2] - The company disclosed its top ten unrestricted shareholders as of April 8, 2025, with HKSCC NOMINEES LIMITED holding approximately 387 million shares, accounting for 13.4% of the total [2] - The total shares held by the top ten circulating shareholders amount to approximately 1.22 billion shares, representing 42.25% of the total shares [2] Shareholder Summary - HKSCC NOMINEES LIMITED: 387 million shares (13.4%) [2] - Hong Kong Central Clearing Limited: 240 million shares (8.31%) [2] - G&C VI Limited: 143 million shares (4.95%) [2] - G&C IV Hong Kong Limited: 105 million shares (3.62%) [2] - Beijing Zhongmin Yinxu Investment Management Co., Ltd.: 87.07 million shares (3.02%) [2] - G&C V Limited: 73.11 million shares (2.53%) [2] - Industrial and Commercial Bank of China - SSE 50 ETF: 48.91 million shares (1.69%) [2] - Industrial and Commercial Bank of China - China Europe Medical Health Mixed Fund: 46.10 million shares (1.6%) [2] - Bank of China - Huabao CSI Medical ETF: 46.01 million shares (1.59%) [2] - China Construction Bank - E Fund CSI 300 Medical and Health ETF: 44.50 million shares (1.54%) [2]